KDR and neoplasm: VEGF receptor 2 (VEGFR2) acts as a major signal transducer in VEGF-regulated angiogenesis, and the inhibition of VEGF/VEGFR2/FAK/paxillin signaling inhibits tumor angiogenesis [104,105].